Cell adhesion, migration and tumor invasion are mediated by the interactions of cell surface adhesion receptors, such as integrins, with adhesion proteins in the extracellular matrix and at the surface of other cells. These interactions have profound influences on malignant cells. For example, fibronectin matrix, when formed around tumorigenic cells, can suppress tumorigenicity in such cells. Moreover, peptides containing the cell adhesion sequence RGD can inhibit tumor cell invasion and tumor dissemination in experimental metastasis models. Peptides that bind to the alpha5beta1 integrin appear to be particularly effective in this regard. In this proposal, phage libraries that display random cyclic peptides will be screened for sequences that bind to integrins that recognize the RGD cell attachment motif. The isolated phage and peptides synthesized according to the peptide motifs carried by these phage will be used to study the recognition specificity and ligand-binding site of the alpha5beta1 integrin. The search will also yield peptides with improved affinity and specificity toward the alpha5beta1 integrin. Comparison of the alpha5beta1 binding sequences to those that bind to another RGD- directed integrin, alpha/v/beta3, will be used to explore the relationships of the specificities of these integrins. These peptides will be tested in various in vitro assays for their ability to interfere with tumor cell attachment, proliferation and migration. These experiments will further the understanding of ligand recognition specificities by integrins and provide improved reagents for the study of integrin roles in tumor growth and metastasis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA028896-15
Application #
5207097
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
15
Fiscal Year
1996
Total Cost
Indirect Cost
McLean, G W; Brown, K; Arbuckle, M I et al. (2001) Decreased focal adhesion kinase suppresses papilloma formation during experimental mouse skin carcinogenesis. Cancer Res 61:8385-9
Assa-Munt, N; Jia, X; Laakkonen, P et al. (2001) Solution structures and integrin binding activities of an RGD peptide with two isomers. Biochemistry 40:2373-8
Baneres, J L; Roquet, F; Martin, A et al. (2000) A minimized human integrin alpha(5)beta(1) that retains ligand recognition. J Biol Chem 275:5888-903
Ellerby, H M; Arap, W; Ellerby, L M et al. (1999) Anti-cancer activity of targeted pro-apoptotic peptides. Nat Med 5:1032-8
Wang, B; Yang, H; Liu, Y C et al. (1999) Isolation of high-affinity peptide antagonists of 14-3-3 proteins by phage display. Biochemistry 38:12499-504
Miura, R; Aspberg, A; Ethell, I M et al. (1999) The proteoglycan lectin domain binds sulfated cell surface glycolipids and promotes cell adhesion. J Biol Chem 274:11431-8
Ruoslahti, E (1999) Fibronectin and its integrin receptors in cancer. Adv Cancer Res 76:1-20
Orend, G; Hunter, T; Ruoslahti, E (1998) Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells. Oncogene 16:2575-83
Kodandapani, R; Veerapandian, L; Ni, C Z et al. (1998) Conformational change in an anti-integrin antibody: structure of OPG2 Fab bound to a beta 3 peptide. Biochem Biophys Res Commun 251:61-6
Arap, W; Pasqualini, R; Ruoslahti, E (1998) Chemotherapy targeted to tumor vasculature. Curr Opin Oncol 10:560-5

Showing the most recent 10 out of 129 publications